A prognostic gene signature for metastasis-free survival of triple negative breast cancer patients

PLoS ONE

Volumn 8, Issue 12, 2013, Pages

  Lee, UnJin ^a   Frankenberger, Casey ^a   Yun, Jieun ^a   Bevilacqua, Elena ^a   Caldas, Carlos ^b   Chin, Suet Feung ^b   Rueda, Oscar M ^b   Reinitz, John ^c   Rosner, Marsha Rich ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PHOSPHATIDYLETHANOLAMINE BINDING PROTEIN;

ARTICLE; BASAL LIKE BREAST CANCER; CANCER PATIENT; CANCER PROGNOSIS; CANCER RISK; CANCER TEST; CONTROLLED STUDY; GENE EXPRESSION ASSAY; GENE EXPRESSION PROFILING; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; METASTASIS FREE SURVIVAL; NUCLEOTIDE SEQUENCE; TRIPLE NEGATIVE BREAST CANCER; TUMOR CLASSIFICATION; TUMOR GENE;

BASIC-LEUCINE ZIPPER TRANSCRIPTION FACTORS; CELL LINE, TUMOR; COHORT STUDIES; DISEASE-FREE SURVIVAL; FANCONI ANEMIA COMPLEMENTATION GROUP PROTEINS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICRORNAS; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PHOSPHATIDYLETHANOLAMINE BINDING PROTEIN; PROGNOSIS; REPRODUCIBILITY OF RESULTS; SIGNAL TRANSDUCTION; TRANSCRIPTOME; TREATMENT OUTCOME; TRIPLE NEGATIVE BREAST NEOPLASMS;

EID: 84892390135     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0082125     Document Type: Article

References (31)

1. Sorlie T, Perou CM, Tibshirani R, Aas T, Geisler S, et al. (2001) Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci U S A 98: 10869-10874.
2. Perou CM, Sorlie T, Eisen MB, van de Rijn M, Jeffrey SS, et al. (2000) Molecular portraits of human breast tumours. Nature 406: 747-752.
3. Parker JS, Mullins M, Cheang MC, Leung S, Voduc D, et al. (2009) Supervised risk predictor of breast cancer based on intrinsic subtypes. J Clin Oncol 27: 1160-1167.
4. Wirapati P, Sotiriou C, Kunkel S, Farmer P, Pradervand S, et al. (2008) Meta-analysis of gene expression profiles in breast cancer: toward a unified understanding of breast cancer subtyping and prognosis signatures. Breast Cancer Res 10: R65.
5. Paik S, Shak S, Tang G, Kim C, Baker J, et al. (2004) A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. N Engl J Med 351: 2817-2826.
6. van 't Veer LJ, Dai H, van de Vijver MJ, He YD, Hart AA, et al. (2002) Gene expression profiling predicts clinical outcome of breast cancer. Nature 415: 530-536.
7. Wang Y, Klijn JG, Zhang Y, Sieuwerts AM, Look MP, et al. (2005) Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer. Lancet 365: 671-679.
8. Sabatier R, Finetti P, Mamessier E, Raynaud S, Cervera N, et al. (2011) Kinome expression profiling and prognosis of basal breast cancers. Mol Cancer 10: 86.
9. Mira A, Isella C, Renzulli T, Cantarella D, Martelli ML, et al. (2009) The GAB2 signaling scaffold promotes anchorage independence and drives a transcriptional response associated with metastatic progression of breast cancer. Oncogene 28: 4444-4455.
10. Pan D, Kocherginsky M, Conzen SD (2011) Activation of the glucocorticoid receptor is associated with poor prognosis in estrogen receptor-negative breast cancer. Cancer Res 71: 6360-6370.
11. Huo D, Ikpatt F, Khramtsov A, Dangou JM, Nanda R, et al. (2009) Population differences in breast cancer: survey in indigenous African women reveals over-representation of triple-negative breast cancer. J Clin Oncol 27: 4515-4521.
12. Bertucci F, Finetti P, Birnbaum D (2012) Basal breast cancer: a complex and deadly molecular subtype. Curr Mol Med 12: 96-110.
13. Minn AJ, Bevilacqua E, Yun J, Rosner MR (2012) Identification of novel metastasis suppressor signaling pathways for breast cancer. Cell Cycle 11: 2452-2457.
14. Yun J, Frankenberger CA, Kuo WL, Boelens MC, Eves EM, et al. (2011) Signalling pathway for RKIP and Let-7 regulates and predicts metastatic breast cancer. EMBO J 30: 4500-4514.
15. Dangi-Garimella S, Yun J, Eves EM, Newman M, Erkeland SJ, et al. (2009) Raf kinase inhibitory protein suppresses a metastasis signalling cascade involving LIN28 and let-7. EMBO J 28: 347-358.
16. Curtis C, Shah SP, Chin SF, Turashvili G, Rueda OM, et al. (2012) The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups. Nature 486: 346-352.
17. Tusher VG, Tibshirani R, Chu G (2001) Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci U S A 98: 5116-5121.
18. Efron B, Tibshirani R (2007) On testing the significance of sets of genes. Ann Appl Stat 1: 107-129.
19. Nelder JA MR (1965) A Simplex Method for Function Minimization. The Computer Journal 7: 308-313.
20. Lehmann BD, Bauer JA, Chen X, Sanders ME, Chakravarthy AB, et al. (2011) Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies. J Clin Invest 121: 2750-2767.
21. McCall MN, Bolstad BM, Irizarry RA (2010) Frozen robust multiarray analysis (fRMA). Biostatistics 11: 242-253.
22. Yamasaki C, Tashiro S, Nishito Y, Sueda T, Igarashi K (2005) Dynamic cytoplasmic anchoring of the transcription factor Bach1 by intracellular hyaluronic acid binding protein IHABP. J Biochem 137: 287-296.
23. Ishikawa M, Numazawa S, Yoshida T (2005) Redox regulation of the transcriptional repressor Bach1. Free Radic Biol Med 38: 1344-1352.
24. Kang Y, Siegel PM, Shu W, Drobnjak M, Kakonen SM, et al. (2003) A multigenic program mediating breast cancer metastasis to bone. Cancer Cell 3: 537-549.
25. Liang Y, Wu H, Lei R, Chong RA, Wei Y, et al. (2012) Transcriptional network analysis identifies BACH1 as a master regulator of breast cancer bone metastasis. J Biol Chem 287: 33533-33544.
26. Venet D, Dumont JE, Detours V (2011) Most random gene expression signatures are significantly associated with breast cancer outcome. PLoS Comput Biol 7: e1002240.
27. Melhem-Bertrandt A, Chavez-Macgregor M, Lei X, Brown EN, Lee RT, et al. (2011) Beta-blocker use is associated with improved relapse-free survival in patients with triple-negative breast cancer. J Clin Oncol 29: 2645-2652.
28. Zenke-Kawasaki Y, Dohi Y, Katoh Y, Ikura T, Ikura M, et al. (2007) Heme induces ubiquitination and degradation of the transcription factor Bach1. Mol Cell Biol 27: 6962-6971.
29. Warnatz HJ, Schmidt D, Manke T, Piccini I, Sultan M, et al. (2011) The BTB and CNC homology 1 (BACH1) target genes are involved in the oxidative stress response and in control of the cell cycle. J Biol Chem 286: 23521-23532.
30. Ladas EJ, Jacobson JS, Kennedy DD, Teel K, Fleischauer A, et al. (2004) Antioxidants and cancer therapy: a systematic review. J Clin Oncol 22: 517-528.
31. Vera-Ramirez L, Sanchez-Rovira P, Ramirez-Tortosa MC, Ramirez-Tortosa CL, Granados-Principal S, et al. (2011) Free radicals in breast carcinogenesis, breast cancer progression and cancer stem cells. Biological bases to develop oxidative-based therapies. Crit Rev Oncol Hematol 80: 347-368.